The Alteration of Clinical and Laboratory Signs and Symptoms of COVID-19 in Re-infection: A Case Report

leili yekefallah; Peyman Namdar; sareh mohammadi

Journal of Inflammatory Diseases

The Official Journal of Qazvin University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Support Contact Us

Authors Guide Submit Manuscript

The Alteration of Clinical and Laboratory Signs and Symptoms of COVID-19 in Re-infection: A Case Report

Author(s):

leili yekefallah

¹,

Peyman Namdar²,

sareh mohammadi^1,*

1Department of Intensive Care Nursing, School of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin, Iran.

2Department of Emergency Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.

Journal of Inflammatory Diseases:Vol. 25, issue 1; 45-50

Article type:issue_documents_importer

How to Cite:leili yekefallahPeyman Namdarsareh mohammadiThe Alteration of Clinical and Laboratory Signs and Symptoms of COVID-19 in Re-infection: A Case Report.J Inflamm Dis.25(1):e156265.

Abstract

Background: Patients can be carriers of the virus for a long time or become re-infected or reinfected following the use of immunosuppressive drugs. Clinical manifestations in patients are very diverse and can range from asymptomatic to severe illness with death. Patients may also present with manifestations such as coagulation disorders, cardiac dysfunction and arrhythmias, acute coronary syndrome, kidney injury, liver injury, Refer to diabetic hyperglycemia and ketoacidosis. This is an essential point in the prevention of Coronavirus Disease 19 (COVID-19). Case Presentation: We reported a case in which the Polymerase Chain Reaction (PCR) test was positive after re-negative after 5 months. Moreover, the patient presented different and more severe symptoms than the previous infection, as the genetic difference between the strains increased over time. Conclusion: As a result, immunization may become more complicated, and different clinical pictures occur; thus, this condition can challenge vaccine immunization.

Keywords

COVID-19

Disease outcomes

COVID-19 symptoms

References

1.
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020; 19(9):767-83. [DOI:10.1016/S1474-4422(20)30221-0].
2.
Cao Ch, Chen M, He L, Xie J, Chen X. Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms. Crit Care. 2020; 24(1):340. [DOI:10.1186/s13054-020-03034-x] [PMID] [PMCID].
3.
Ai JW, Zi H, Wang Y, Huang Q, Wang N, Li LY, et al. Clinical characteristics of COVID-19 patients With gastrointestinal symptoms: An analysis of seven patients in China. Front Med.2020; 7:308. [DOI:10.3389/fmed.2020.00308] [PMID] [PMCID].
4.
Ciceri F, Castagna A, Rovere-Querini P, De Cobelli F, Ruggeri A, Galli L, et al. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020; 217:108509.[DOI:10.1016/j.clim.2020.108509] [PMID] [PMCID].
5.
Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, et al. A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID-19 glob-al pandemic. Am J Med Sci. 2020; 360(1):5-34. [DOI:10.1016/j.amjms.2020.05.006] [PMID] [PMCID].
6.
Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J Infect. 2020; 81(5):816-46. [DOI:10.1016/j.jinf.2020.06.073][PMID] [PMCID].
7.
Parra LM, Cantero M, Morrs I, Vallejo A, Diego I, Jimnez-Tejero E, et al. Hospital readmissions of discharged patients with COVID-19. Int J Gen Med. 2020; 13:1359-66.[DOI:10.2147/IJGM.S275775] [PMID] [PMCID].
8.
de Araujo Torres D, do Carmo Bueno Ribeiro L, de Freitas Linhares Riello AP, Horovitz DDG, Pinto LFR, Croda J. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report. J Med Virol. 2021; 93(4):1857-9. [DOI:10.1002/jmv.26637] [PMID].
9.
Roy S. COVID-19 reinfection: Myth or truth? SN Compr Clin Med. 2020; 2(6):710-3. [DOI:10.1007/s42399-020-00335-8][PMID] [PMCID].
10.
Porras Villamil JF, Olivera MJ. COVID-19: Is reinfection a threat or not? Iran J Public Health. 2020; 49(Suppl 1):112-3. [DOI:10.18502/ijph.v49iS1.3678].
11.
Loconsole D, Passerini F, Palmieri VO, Centrone F, Sallustio A, Pugliese S, et al. Recurrence of COVID-19 after recovery: A case report from Italy. Infection. 2020; 48(6):965-7.[DOI:10.1007/s15010-020-01444-1] [PMID] [PMCID].
12.
Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARS-CoV-2: A case study. Lancet Infect Dis. 2021; 21(1):52-8.[DOI:10.1016/S1473-3099(20)30764-7].
13.
Jeremias S. First case of COVID-19 reinfection detected in the US [Internet]. 2020 [Updated 2020 October 12]. Available from: https://www.ajmc.com/view/first-case-of-covid-19-reinfection-detected-in-the-us.
14.
Hanif M, Haider MA, Ali MJ, Naz S, Sundas F. Reinfection of COVID-19 in Pakistan: A first case report. Cureus. 2020; 12 (10):e11176. [DOI:10.7759/cureus.11176].
15.
Alonso FOM, Sabino BD, Guimares MAAM, Varella RB. Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: Case report. J Med Virol. 2021; 93(2):655-6. [DOI:10.1002/jmv.26432] [PMID] [PMCID].
16.
He S, Sun W, Zhou K, Hu M, Liu Ch, Xie L, et al. Clinical characteristics analysis of the Re-positive discharged COVID-19 pneumonia patients in Wuhan, China [Internet]. 2020 [Updated 2020 May 13]. Available from: https://www.researchsquare. com/article/rs-28667/v1 [DOI:10.21203/rs.3.rs-28667/v1]##.

comments